S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
Is This The End of Capitalism? (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
OTCMKTS:MRMD

MariMed - MRMD Stock Forecast, Price & News

$0.41
0.00 (0.00%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.40
$0.41
50-Day Range
$0.36
$0.55
52-Week Range
$0.28
$0.90
Volume
278,392 shs
Average Volume
261,978 shs
Market Capitalization
$139.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.85

MariMed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
106.3% Upside
$0.85 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-33.33%
From $0.03 to $0.02 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars


MRMD stock logo

About MariMed (OTCMKTS:MRMD) Stock

MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.

Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

MRMD Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
MariMed searches for new CEO after death of Robert Fireman
MariMed Announces Participation In Upcoming Conferences
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
MariMed Announces Participation In Upcoming Conferences
MariMed Supports Giving At Thanksgiving
MariMed Reports Third Quarter 2022 Earnings
3 Cannabis Stock Predictions for 2023 - InvestorPlace
MariMed Announces Third Quarter 2022 Earnings Date
MariMed Inc. (MRMD)
Form DEF 14A MARIMED INC. For: Sep 22 - StreetInsider.com
See More Headlines
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

MRMD Company Calendar

Last Earnings
11/07/2022
Today
1/30/2023
Next Earnings (Estimated)
3/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MRMD
Fax
N/A
Employees
260
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$0.85
High Stock Price Forecast
$0.85
Low Stock Price Forecast
$0.85
Forecasted Upside/Downside
+106.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$7.22 million
Pretax Margin
13.56%

Debt

Sales & Book Value

Annual Sales
$121.46 million
Cash Flow
$0.07 per share
Book Value
$0.11 per share

Miscellaneous

Free Float
260,232,000
Market Cap
$139.86 million
Optionable
Not Optionable
Beta
3.28

Key Executives

  • Jon R. Levine
    President, CEO, Secretary, Treasurer & Director
  • Timothy Shaw
    Chief Operating Officer
  • Susan M. Villare
    Chief Financial Officer
  • Jay O’Malley
    Vice President-Marketing & Research & Development
  • Ryan Crandall
    Chief Revenue Officer













MRMD Stock - Frequently Asked Questions

Should I buy or sell MariMed stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MariMed in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MRMD shares.
View MRMD analyst ratings
or view top-rated stocks.

What is MariMed's stock price forecast for 2023?

3 Wall Street research analysts have issued 1-year price targets for MariMed's stock. Their MRMD share price forecasts range from $0.85 to $0.85. On average, they anticipate the company's share price to reach $0.85 in the next twelve months. This suggests a possible upside of 106.3% from the stock's current price.
View analysts price targets for MRMD
or view top-rated stocks among Wall Street analysts.

How have MRMD shares performed in 2023?

MariMed's stock was trading at $0.3562 at the beginning of 2023. Since then, MRMD stock has increased by 15.7% and is now trading at $0.4120.
View the best growth stocks for 2023 here
.

Are investors shorting MariMed?

MariMed saw a decline in short interest in December. As of December 15th, there was short interest totaling 9,900 shares, a decline of 23.3% from the November 30th total of 12,900 shares. Based on an average daily volume of 1,117,200 shares, the short-interest ratio is currently 0.0 days.
View MariMed's Short Interest
.

When is MariMed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 14th 2023.
View our MRMD earnings forecast
.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) posted its quarterly earnings data on Monday, November, 7th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. The business earned $33.91 million during the quarter, compared to the consensus estimate of $34.20 million. MariMed had a net margin of 1.79% and a trailing twelve-month return on equity of 5.18%.

What guidance has MariMed issued on next quarter's earnings?

MariMed updated its FY 2022 earnings guidance on Monday, November, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $132.00 million-$135.00 million, compared to the consensus revenue estimate of $135.80 million.

What other stocks do shareholders of MariMed own?
What is MariMed's stock symbol?

MariMed trades on the OTCMKTS under the ticker symbol "MRMD."

How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MariMed's stock price today?

One share of MRMD stock can currently be purchased for approximately $0.41.

How much money does MariMed make?

MariMed (OTCMKTS:MRMD) has a market capitalization of $139.86 million and generates $121.46 million in revenue each year.

How many employees does MariMed have?

The company employs 260 workers across the globe.

How can I contact MariMed?

MariMed's mailing address is 11 ROYAL ROAD, BROOKLINE MA, 02445. The official website for the company is marimedadvisors.com. The company can be reached via phone at (617) 795-5140 or via email at ir@mattio.com.

This page (OTCMKTS:MRMD) was last updated on 1/31/2023 by MarketBeat.com Staff